An editorial has explained the importance of ensuring vaccination for the prevention of H1N1 influenza virus, which should figure topmost on experts' agenda.
Written by Paul Hebert, the Editor-in-Chief of Canadian Medical Association Journal (CMAJ), the editorial points out that Canada and many other Western countries lack experience in mass immunization campaigns.
AdvertisementThe author suggests that scientists start planning how to overcome these problems.
In Canada, leadership is needed to ensure access to vaccines and to the expertise and equipment to help deal with this pandemic.
The write-up even stresses the need for a national champion who has proper powers across all jurisdictions, and accountability to the highest office in the country.
It further says that there is a need for local leaders, and other champions who will collaborate and cooperate to ensure rapid response.
"In countries such as Canada that have shared responsibilities between many levels of government, collaboration and clear communication are essential as a first line of defence. To see that this happens, governments need to have or enact laws to provide the necessary power to ensure rapid action on complex issues," write Dr. Hébert and the CMAJ editorial writing team.
If disease patterns in the northern hemisphere follow those in the southern hemisphere, Europe and North America will most likely experience a second wave of H1N1 cases this fall and our resources could be overwhelmed.
In most areas, planning has not yet included how to secure experienced health care professionals to deliver technologies to help patients survive.
"This is not a time for complacency. The health czar and other national leaders should immediately convene a summit to link public health officials, the critical care community, first responders, and other health care providers, decision-makers, community planners and the public, to communicate next steps and to ensure that actions taken by leaders will work at the ground level," concludes the editorial.
P Smoking may Lead to Brain Damage in Multiple Sclerosis Patients Negativity Increases Risk of Mortality in Peripheral Arterial Disease Patients' M
You May Also Like